Your browser doesn't support javascript.
loading
The Non-Significant Benefit of BCG Vaccination for the Treatment of Iranian Patients with Type 1 Diabetes up to 48 Weeks: A Controversial Result.
Moghtaderi, Mozhgan; Zarei, Parisa; Shakerian, Behzad; Babaei, Maryam; Mostafavi, Ali; Modaressi, Mahboubeh.
Affiliation
  • Moghtaderi M; Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Zarei P; Diabetic Clinic of Ali-Asghar Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Shakerian B; Immunology Department of Shariati Hospital, Isfahan, Iran.
  • Babaei M; Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Mostafavi A; Sharif University of Technology, Tehran, Iran.
  • Modaressi M; Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Med J Islam Repub Iran ; 35: 161, 2021.
Article in En | MEDLINE | ID: mdl-35465168
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Observational_studies Language: En Journal: Med J Islam Repub Iran Year: 2021 Type: Article Affiliation country: Iran
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Observational_studies Language: En Journal: Med J Islam Repub Iran Year: 2021 Type: Article Affiliation country: Iran